Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
A young child with an inherited tumor-predisposition syndrome develops recurrent bilateral visual decline after completing first-line chemotherapy for a radiographically diagnosed optic pathway tumor, requiring reassessment of treatment urgency, systemic options, and surveillance.
Medical Genetics October 19th 2026